Delcath Systems Inc (DCTH.OQ)

DCTH.OQ on NASDAQ Stock Exchange Capital Market

2.29USD
4:00pm EDT
Price Change (% chg)

$-0.19 (-7.66%)
Prev Close
$2.48
Open
$2.49
Day's High
$2.49
Day's Low
$2.27
Volume
20,018
Avg. Vol
16,305
52-wk High
$10.56
52-wk Low
$1.90

DCTH.OQ

Chart for DCTH.OQ

About

Delcath Systems, Inc. (Delcath) is a development-stage, specialty pharmaceutical and medical device company, focused on oncology, initially cancers in the liver. Delcath focuses on the development and clinical study of the Delcath chemosaturation system. The Delcath chemosaturation system allows the administration of concentrate... (more)
No analyst recommendations are available for DCTH.OQ.

Overall

Beta: 2.42
Market Cap (Mil.): $23.44
Shares Outstanding (Mil.): 9.45
Dividend: --
Yield (%): --

Financials

  DCTH.OQ Industry Sector
P/E (TTM): -- 32.07 33.47
EPS (TTM): -2.83 -- --
ROI: -74.16 8.58 17.39
ROE: -75.13 12.00 18.25
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks